380 related articles for article (PubMed ID: 22929563)
1. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
Wang W; Zhang HT; Yang XL
J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
[TBL] [Abstract][Full Text] [Related]
2. [Role of matrix metalloproteinase and tissue inhibitor of metalloproteinase in atrial structural remodeling in patients with atrial fibrillation].
Wang W; Wu PS; Yang XL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1160-2. PubMed ID: 20501421
[TBL] [Abstract][Full Text] [Related]
3. [Changes in gelatinases expression and activity in human atria during atrial fibrillation].
Ke D; Xu CX; Zhang JC; Chen L; Lin YZ; Lin LF; Hu XZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):137-42. PubMed ID: 15924808
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of right atrial matrix metalloproteinase expression between patients with unstable angina and myocardial infarction].
Wang W; Wu PS; Yang XL
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 May; 38(5):411-4. PubMed ID: 20654099
[TBL] [Abstract][Full Text] [Related]
5. [Clinical on molecular basis of atrial fibrosis in patients with atrial fibrillation investigation].
Ke D; Xu CX; Lin YZ; Zhang JC; Chen L; Lin LF; Hu XZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):459-63. PubMed ID: 15932710
[TBL] [Abstract][Full Text] [Related]
6. [Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation].
Zhu H; Zhang W; Guo CH; Zhang G; Zhang WD; Zhong M; Yang GR; Ge ZM; Zhang Y
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):45-8. PubMed ID: 15808077
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
[TBL] [Abstract][Full Text] [Related]
8. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
Mukherjee R; Herron AR; Lowry AS; Stroud RE; Stroud MR; Wharton JM; Ikonomidis JS; Crumbley AJ; Spinale FG; Gold MR
Am J Cardiol; 2006 Feb; 97(4):532-7. PubMed ID: 16461051
[TBL] [Abstract][Full Text] [Related]
9. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease.
Sun Y; Huang ZY; Wang ZH; Li CP; Meng XL; Zhang YJ; Su F; Ma N
Mol Cell Biochem; 2015 Aug; 406(1-2):131-8. PubMed ID: 25971370
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
[TBL] [Abstract][Full Text] [Related]
12. Role of metalloproteinases and tissue inhibitors of metalloproteinases during cardiopulmonary bypass in rats.
Guenzinger R; Lahm H; Wottke M; Lange R
ASAIO J; 2012; 58(3):204-11. PubMed ID: 22395114
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of matrix metalloproteinases activity in acute myocardial infarction.
Papadopoulos DP; Moyssakis I; Makris TK; Poulakou M; Stavroulakis G; Perrea D; Votteas VE
Eur Cytokine Netw; 2005 Jun; 16(2):152-60. PubMed ID: 15941687
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.
Nakano Y; Niida S; Dote K; Takenaka S; Hirao H; Miura F; Ishida M; Shingu T; Sueda T; Yoshizumi M; Chayama K
J Am Coll Cardiol; 2004 Mar; 43(5):818-25. PubMed ID: 14998623
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of matrix metalloproteinase-1,9, tissue inhibitor of metalloproteinase-4 and extracellular matrix metalloproteinase inducer in the myocardium of congestive heart failure in patients with rheumatic heart diseases].
Zhao Y; Zhou X; Liao X; Yang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 34(8):790-5. PubMed ID: 19734590
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation.
Cong H; Li X; Ma L; Jiang H; Mao Y; Xu M
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):298-304. PubMed ID: 20080265
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC
Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
An Z; Yang G; He YQ; Dong N; Ge LL; Li SM; Zhang WQ
Chin Med J (Engl); 2013; 126(11):2149-56. PubMed ID: 23769575
[TBL] [Abstract][Full Text] [Related]
19. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
Brunner S; Kim JO; Methe H
Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
[TBL] [Abstract][Full Text] [Related]
20. [Atrial 11beta-hydroxysteroid dehydrogenase type 2 expression in rheumatic heart disease patients with or without atrial fibrillation].
Pei DA; Li L; Xu ZY; Huang JY; Xu ZM; Wang M
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 May; 36(5):385-9. PubMed ID: 19100026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
